Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00757224|
Recruitment Status : Unknown
Verified September 2008 by Assaf-Harofeh Medical Center.
Recruitment status was: Not yet recruiting
First Posted : September 23, 2008
Last Update Posted : September 23, 2008
Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants.
Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided shortly after the infant is born, will decrease infants' morbidity.
|Condition or disease||Intervention/treatment|
|Tobacco Smoke Pollution||Behavioral: Guidance|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||October 2008|
|Estimated Primary Completion Date :||November 2008|
|Estimated Study Completion Date :||October 2009|
|No Intervention: non-smoking|
|No Intervention: smoking parents A|
Experimental: smoking parents B
Parents will be educated on the hazards of passive smoke exposure and ways to reduce it
Smoking parents will receive education on the association between parental smoking and respiratory morbidity in the infant. They will also be offered ways to reduce smoke exposure of their infants.
- The number of episodes of cough/wheeze/asthma/bronchitis during the first 3 months and 1 year. [ Time Frame: 3 months and 1 year ]
- The number of ED visits and hospitalizations for respiratory diseases in the first 3 months and 1 year [ Time Frame: 3 months and 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00757224
|Contact: Arnon Elizur, MDemail@example.com|
|Asaf Harofeh Medical Center||Not yet recruiting|
|Zerifin, Israel, 70300|
|Contact: Arnon Elizur, MD 972-8-9779817 firstname.lastname@example.org|